Marshall Wace’s LeonaBio Inc LONA Stock Holding History

Marshall Wace’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,068	Closed	-$26.7K	–	2451
2023 Q1	$26.7K	Buy	+1,068	New	+$34.4K	﹤0.01%	2566

Other funds holding LONA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Marshall Wace's LONA Position: Q2 2023 in Review

Marshall Wace sold out of LeonaBio Inc (LONA) in Q2 2023, closing a stake of 1,068 shares — an estimated $26.7K sold.

Marshall Wace first reported a position in LONA in Q1 2023 and held it in 1 quarter. The position peaked at $26.7K in Q1 2023. 77 funds tracked by Wall St. Rank hold LONA as of Q2 2023.

Marshall Wace reported no remaining LeonaBio Inc position as of Q2 2023 after selling out during the quarter.
Marshall Wace sold 1,068 LeonaBio Inc shares in Q2 2023, an estimated $26.7K.
Marshall Wace first reported a position in LeonaBio Inc in Q1 2023 and held it in 1 quarter.
Marshall Wace's LeonaBio Inc position peaked at $26.7K in Q1 2023.
77 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2023.

Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.